Shenling Baizhu Powder Alleviates TNBS-Induced Colitis in Rats by Improving Intestinal Epithelial Permeability and Inhibiting Inflammation Through the TLR5/MyD88/NF-κB Pathway

Kehan Rao(Guangzhou University of Chinese Medicine), Shaogang Huang(Guangzhou University of Chinese Medicine), Kai Zhan(Guangzhou University of Chinese Medicine), Shumin Qin(Guangzhou University of Chinese Medicine), Yuanming Yang(Guangzhou University of Chinese Medicine), Haomeng Wu(Guangzhou University of Chinese Medicine), Huan Zheng(Guangzhou University of Chinese Medicine)
Frontiers in Pharmacology
April 28, 2022
10.3389/fphar.2022.883918
Cited by 18

Related Papers

Altered metabolome and microbiome features provide clues in understanding irritable bowel syndrome and depression comorbidity
|The ISME Journal|2021|120
Biomarkers prediction and immune landscape in ulcerative colitis: Findings based on bioinformatics and machine learning
|Computers in Biology and Medicine|2023|47
Clinical evidence of acupuncture and moxibustion for irritable bowel syndrome: A systematic review and meta-analysis of randomized controlled trials
|Frontiers in Public Health|2022|28
The function of the gut microbiota–bile acid–TGR5 axis in diarrhea-predominant irritable bowel syndrome
|mSystems|2024|25
Therapeutic targets and pharmacological mechanisms of Coptidis Rhizoma against ulcerative colitis: Findings of system pharmacology and bioinformatics analysis
|Frontiers in Pharmacology|2022|23